Michele Rizzo

Deferiprone versus Deferoxamine in Patients with Thalassemia Major: A Randomized Clinical Trial

Aurelio Maggio, Gennaro D’Amico, Alberto Morabito et al. · Blood Cells Molecules and Diseases · 2002 · 190 citations

Medicine, Hematology, Pharmacology +8

Improving survival with deferiprone treatment in patients with thalassemia major: A prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies

Aurelio Maggio, Angela Vitrano, Marcello Capra et al. · Blood Cells Molecules and Diseases · 2009 · 96 citations

Medicine, Hematology, Pharmacology +6

Long‐term sequential deferiprone–deferoxamine <i>versus</i> deferiprone alone for thalassaemia major patients: a randomized clinical trial

Aurelio Maggio, Angela Vitrano, Marcello Capra et al. · British Journal of Haematology · 2009 · 70 citations

Medicine, Pharmacology, Pharmacotherapy +14

The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major‐intermedia dichotomy?

Angela Vitrano, Giuseppina Calvaruso, Eliana Lai et al. · British Journal of Haematology · 2016 · 56 citations · Full text

Medicine, Hematology, Internal Medicine +12

Long‐term use of deferiprone significantly enhances left‐ventricular ejection function in thalassemia major patients

Aurelio Maggio, Angela Vitrano, Gaetano Lucania et al. · American Journal of Hematology · 2012 · 36 citations · Full text

Medicine, Cardiology, Pharmacotherapy +14